US Stocks
/
Aprea Therapeutics, Inc. Share Price

Aprea Therapeutics, Inc. Share Price

NASDAQ: APRE | Micro Cap
$0.56
-$0.03 (-5.59%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aprea Therapeutics, Inc. Stock Performance

Open
$0.60
Prev. Close
$0.59
Circuit Range
N/A
Day Range
$0.55 - $0.60
Year Range
$0.55 - $1.68
Volume
1,500
Average Traded
$0.56

Aprea Therapeutics, Inc. Share Price Today

As of 9 October 2026, Aprea Therapeutics, Inc.'s share price is $0.56. The stock opened at $0.60, compared to its previous close of $0.59. During today's trading session, Aprea Therapeutics, Inc.'s share price traded between $0.55 and $0.60, with an average price of $0.58. Over the past 52 weeks, the stock has recorded a high of $1.68 and a low of $0.55. In terms of performance, Aprea Therapeutics, Inc.'s share price has declined by 29.50% over the last six months and is down 60.48% on a year-on-year basis.

Aprea Therapeutics, Inc. Share Price Chart

$0.55$0.60
L
Show Current Price
H

Aprea Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.67M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.98
Revenue (TTM)
$290.00M
Return On Equity (TTM)
-31.99%
Profit Margin
-4344.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-20.88%

Aprea Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.97-$2.46-$3.29-$3.59
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A17.17%-33.74%-9.12%

Aprea Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.58$1.50$0.29
Net Profit-$112.66-$14.29-$12.96-$12.60
Net Profit MarginN/A-2463.79%-864.00%-4344.83%
Income ChangeN/A87.32%9.31%2.78%

About Aprea Therapeutics, Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

Aprea Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.69
$0.56
-28.08%
Sep 2026
$0.80
$0.78
-13.24%
Aug 2026
$0.59
$0.90
+38.10%
Jul 2026
$0.79
$0.65
-14.90%
Jun 2026
$0.83
$0.77
-17.30%
May 2026
$0.81
$0.93
+16.21%
Apr 2026
$0.71
$0.80
+0.89%
Mar 2026
$0.87
$0.79
-12.43%
Feb 2026
$0.73
$0.90
+15.51%
Jan 2026
$0.86
$0.78
-8.56%
Dec 2025
$1.23
$0.85
-32.83%
Nov 2025
$1.41
$1.27
-10.56%

APRE Share Price FAQs

What is Aprea Therapeutics, Inc. share price today?

chevron-up
Aprea Therapeutics, Inc. share price today is $0.56 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Aprea Therapeutics, Inc. stock?

chevron-up
The 52 week high of Aprea Therapeutics, Inc. stock is $1.68, while the 52 week low is $0.55 as of 9 Oct '26.

What is APRE's market capitalisation today?

chevron-up
APRE market capitalisation is $3.67M as of October 9, 2026, at 4:46 pm IST.

What is APRE's net income for the last quarter?

chevron-up
APRE's net income for the last quarter is -3.59B USD.

What is the 5 year returns of APRE?

chevron-up
The 5 year returns of APRE is -99.44% as on 9 Oct '26.

What is the high & low stock price of APRE today?

chevron-up
APRE stock price hit a high of $0.60 and low of $0.55 as of 9 Oct '26.

Can I buy APRE shares in India?

chevron-up
Yes. You can buy APRE in India by opening an international trading account.